Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Mor

Showing results (71-80 of 168) with videos related to

Pageof 17
Sort By:
The Mount Sinai Journal of Medicine, New York|January 1, 1994
Liver transplantation for hepatocellular carcinoma: experience at The Mount Sinai HospitalS Chiodini, M W Sung, P Sheiner, et al.
Business and Health|March 10, 1991
Golden oldies: striking a balance in retiree health careM E Mor-Barak, A E Scharlach, M Tynan, et al.
Transplantation Proceedings|March 20, 2003
Combination hepatitis B immune globulin and lamivudine versus hepatitis B immune globulin monotherapy in preventing recurrent hepatitis B virus infection in liver transplant recipientsZ Ben-Ari, E Mor, N Bar-Nathan, et al.
Transplantation Proceedings|March 20, 2003
Comparison of tacrolimus with cyclosporin as primary immunosuppression in patients with hepatitis C virus infection after liver transplantationZ Ben-Ari, E Mor, N Bar-Nathan, et al.
Pediatric Transplantation|May 19, 2010
The efficacy and safety of valganciclovir vs. oral ganciclovir in the prevention of symptomatic CMV infection in children after solid organ transplantationE Lapidus-Krol, R Shapiro, J Amir, et al.
Biokhimiia (Moscow, Russia)|February 1, 1989
[Cumene hydroperoxide changes the type of conductivity of the mitochondrial membrane for K+]S A Novgorodov, T I Gudz', Iu E Mor, et al.
Transplantation Proceedings|June 17, 2000
Thrombotic microangiopathy early after kidney transplantation: hemolytic uremic syndrome or vascular rejection?E Mor, S Lustig, A Tovar, et al.
Transplantation Proceedings|June 17, 2000
Combination of interferon-alpha and ribavirin therapy for recurrent hepatitis C virus infection after liver transplantationZ Ben-Ari, E Mor, E Shaharabani, et al.
Transplantation|August 15, 1994
Reversal of severe FK506 side effects by conversion to cyclosporine-based immunosuppressionE Mor, P A Sheiner, M E Schwartz, et al.
Transplantation Proceedings|June 17, 2000
Conversion of liver allograft recipients from cyclosporine A to FK 506 immunosuppressive therapyZ Ben-Ari, E Mor, E Shaharabani, et al.
Pageof 17

Showing results (71-80 of 168) with videos related to

Sort By:
Pageof 17
The Mount Sinai Journal of Medicine, New York|January 1, 1994
Liver transplantation for hepatocellular carcinoma: experience at The Mount Sinai HospitalS Chiodini, M W Sung, P Sheiner, et al.
Business and Health|March 10, 1991
Golden oldies: striking a balance in retiree health careM E Mor-Barak, A E Scharlach, M Tynan, et al.
Transplantation Proceedings|March 20, 2003
Combination hepatitis B immune globulin and lamivudine versus hepatitis B immune globulin monotherapy in preventing recurrent hepatitis B virus infection in liver transplant recipientsZ Ben-Ari, E Mor, N Bar-Nathan, et al.
Transplantation Proceedings|March 20, 2003
Comparison of tacrolimus with cyclosporin as primary immunosuppression in patients with hepatitis C virus infection after liver transplantationZ Ben-Ari, E Mor, N Bar-Nathan, et al.
Pediatric Transplantation|May 19, 2010
The efficacy and safety of valganciclovir vs. oral ganciclovir in the prevention of symptomatic CMV infection in children after solid organ transplantationE Lapidus-Krol, R Shapiro, J Amir, et al.
Biokhimiia (Moscow, Russia)|February 1, 1989
[Cumene hydroperoxide changes the type of conductivity of the mitochondrial membrane for K+]S A Novgorodov, T I Gudz', Iu E Mor, et al.
Transplantation Proceedings|June 17, 2000
Thrombotic microangiopathy early after kidney transplantation: hemolytic uremic syndrome or vascular rejection?E Mor, S Lustig, A Tovar, et al.
Transplantation Proceedings|June 17, 2000
Combination of interferon-alpha and ribavirin therapy for recurrent hepatitis C virus infection after liver transplantationZ Ben-Ari, E Mor, E Shaharabani, et al.
Transplantation|August 15, 1994
Reversal of severe FK506 side effects by conversion to cyclosporine-based immunosuppressionE Mor, P A Sheiner, M E Schwartz, et al.
Transplantation Proceedings|June 17, 2000
Conversion of liver allograft recipients from cyclosporine A to FK 506 immunosuppressive therapyZ Ben-Ari, E Mor, E Shaharabani, et al.
Pageof 17